CN106215221A - Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof - Google Patents
Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof Download PDFInfo
- Publication number
- CN106215221A CN106215221A CN201610780586.7A CN201610780586A CN106215221A CN 106215221 A CN106215221 A CN 106215221A CN 201610780586 A CN201610780586 A CN 201610780586A CN 106215221 A CN106215221 A CN 106215221A
- Authority
- CN
- China
- Prior art keywords
- gelatin
- oligochitosan
- akermanite
- biological dressing
- nanofiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Textile Engineering (AREA)
- Inorganic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了壳寡糖‑明胶‑镁黄长石纳米纤维生物敷料及其制备方法。具体而言,该敷料由包含壳寡糖、明胶、镁黄长石和溶剂的凝胶混悬液通过静电纺丝的方法制备而成。本发明的复合型纳米纤维生物敷料克服了单一敷料成分的弊端,更加适应皮肤组织的生物多样性和复杂性,既保证了创口处于湿性环境下,有利于加速血管形成,促进肉芽组织的形成,又保持了创面的恒温,有利于组织的无结痂愈合,并且具有良好的保湿性、透气性、抑菌性、生物相容性,并且操作方便,易于使用。The invention discloses a chitosan-gelatin-magnesia feldspar nanofiber biological dressing and a preparation method thereof. Specifically, the dressing is prepared by an electrospinning method from a gel suspension comprising chitosan oligosaccharide, gelatin, feldspar and solvent. The composite nanofiber biological dressing of the present invention overcomes the disadvantages of a single dressing component, and is more suitable for the biological diversity and complexity of skin tissue. It not only ensures that the wound is in a humid environment, but also helps to accelerate the formation of blood vessels and promote the formation of granulation tissue. It also maintains the constant temperature of the wound surface, which is conducive to the healing of tissues without scabs, and has good moisture retention, air permeability, bacteriostasis, and biocompatibility, and is easy to operate and use.
Description
技术领域technical field
本发明属于医用材料技术领域,涉及一种包含壳寡糖、明胶和镁黄长石的复合纳米纤维生物敷料及其制备方法。The invention belongs to the technical field of medical materials, and relates to a composite nanofiber biological dressing containing chitosan oligosaccharide, gelatin and feldspar and a preparation method thereof.
背景技术Background technique
近年来,关于甲壳质和壳聚糖(脱乙酰甲壳质)的研究已在国内外广泛展开,它们在抗肿瘤、制备创伤敷料、防治病源微生物等方面的功能得到肯定。但因其不溶于水,在开发应用上受到很大限制。通过适当的方法将壳聚糖降解为壳寡糖(又称寡聚氨基葡萄糖、甲壳低聚糖,聚合度通常在2~20之间)后,发现其不但水溶性好,易被人体吸收,生物利用度高,而且具有抑菌、抗肿瘤、调血脂、调节免疫、促进伤口愈合等多种生理功能。研究发现,壳寡糖具有止血、加强炎症和修复细胞的功能,从而能够加速伤口愈合,将其用作伤口敷料可以得到更直接的治疗效果。In recent years, research on chitin and chitosan (chitosan) has been widely carried out at home and abroad, and their functions in anti-tumor, preparation of wound dressings, and prevention and treatment of pathogenic microorganisms have been affirmed. But because it is insoluble in water, its development and application are greatly limited. After degrading chitosan into chitooligosaccharides (also known as oligoglucosamine and chitooligosaccharides, the degree of polymerization is usually between 2 and 20) by appropriate methods, it is found that it is not only good in water solubility, but also easily absorbed by the human body. It has high bioavailability, and has various physiological functions such as antibacterial, antitumor, blood lipid regulation, immune regulation, and wound healing promotion. Studies have found that chitosan has the functions of hemostasis, strengthening inflammation and repairing cells, thereby accelerating wound healing, and using it as a wound dressing can obtain a more direct therapeutic effect.
明胶是胶原蛋白部分水解的产物,其氨基酸组成和胶原相似,生物相容性好,并且具有亲水性强、成膜性好、可生物降解、呈典型的两性电介质特征等诸多优良的物理与化学性质,可用作止血海绵、敷料、药物载体,明胶超细纤维可以模拟人体各类组织和器官的细胞外基质结构,应用于生物医药、组织工程等领域。Gelatin is a product of partial hydrolysis of collagen. Its amino acid composition is similar to that of collagen, and it has good biocompatibility. Chemical properties, can be used as hemostatic sponges, dressings, drug carriers, gelatin microfibers can simulate the extracellular matrix structure of various tissues and organs of the human body, and are used in biomedicine, tissue engineering and other fields.
镁黄长石(Ca2MgSi2O7)是一种含钙镁硅的生物活性陶瓷,具有足够的力学强度,良好的生物相容性,合适的降解速度和三维多孔结构,在构建组织工程骨方面已有报道。镁黄长石通过类似于羟基磷灰石的钙磷层与活体组织形成骨性结合,阻止了纤维囊的形成,同时也减小了组织修复失败的可能性。Magnesite feldspar (Ca 2 MgSi 2 O 7 ) is a calcium-magnesium-silicon-containing bioactive ceramic with sufficient mechanical strength, good biocompatibility, suitable degradation rate and three-dimensional porous structure. It has been reported. Magnesite feldspar forms an osseointegration with living tissue through a calcium-phosphorus layer similar to hydroxyapatite, which prevents the formation of fibrous capsules and reduces the possibility of tissue repair failure.
目前,临床上对于创伤敷料的需求量日益增大(例如在烧伤、外部创伤、长期不愈性溃疡、手术后伤口护理等情况下),而传统敷料却渐渐显露出不透气、换药易破坏新生肉芽组织、患者体感差等弊端。现代医学则提倡湿性愈合,认为湿性环境更容易促进伤口的愈合,原因在于湿性愈合加速血管形成,促进肉芽组织的形成,同时湿性环境保持了创面的恒温,有利于组织的无结痂愈合,避免了新生肉芽组织再次遭受机械性损伤,减轻疼痛。At present, there is an increasing demand for wound dressings clinically (such as burns, external trauma, long-term non-healing ulcers, post-operative wound care, etc.), while traditional dressings are gradually becoming airtight and easy to damage when changing dressings. Disadvantages such as new granulation tissue and poor physical sensation of patients. Modern medicine advocates moist healing, and believes that a moist environment is more likely to promote wound healing. The reason is that moist healing accelerates the formation of blood vessels and promotes the formation of granulation tissue. The new granulation tissue will suffer mechanical injury again, and the pain will be relieved.
由于皮肤组织的生物多样性和复杂性,单一成分的敷料远远不能满足皮肤组织修复需求,因此亟待开发一种利用复合材料制备的敷料,来满足相关需求。Due to the biodiversity and complexity of skin tissue, single-component dressings are far from meeting the needs of skin tissue repair. Therefore, it is urgent to develop a dressing made of composite materials to meet related needs.
发明内容Contents of the invention
针对上述情况,本发明的目的在于提供一种壳寡糖-明胶-镁黄长石纳米纤维生物敷料及其制备方法。本发明通过联合使用壳寡糖、明胶和镁黄长石,并利用静电纺丝技术将上述三种成分制成纳米纤维湿性敷料,所得产品具有良好的保湿性、透气性、抑菌性、生物相容性,能够促进血管生成和组织再生,操作方便,临床效果明显,在创伤修复领域发挥重要作用。In view of the above situation, the object of the present invention is to provide a kind of oligochitosan-gelatin-magnesia feldspar nanofiber biological dressing and its preparation method. The present invention uses chitosan oligosaccharide, gelatin and feldspar in combination, and utilizes electrospinning technology to make nanofiber wet dressing from the above three components. It can promote angiogenesis and tissue regeneration, is easy to operate, has obvious clinical effects, and plays an important role in the field of wound repair.
为了达到上述目的,本发明采用如下技术方案:In order to achieve the above object, the present invention adopts following technical scheme:
一种壳寡糖-明胶-镁黄长石纳米纤维生物敷料,其由包含壳寡糖、明胶、镁黄长石和溶剂的凝胶混悬液通过静电纺丝的方法制备而成。A chitosan oligosaccharide-gelatin-magnesia feldspar nanofiber biological dressing is prepared from a gel suspension comprising chitosan oligosaccharide, gelatin, magnesia feldspar and a solvent through an electrospinning method.
优选的,在上述生物敷料中,所述凝胶混悬液中壳寡糖的质量浓度为0.1~5g/100mL,优选0.3~3g/100mL。Preferably, in the above-mentioned biological dressing, the mass concentration of chitosan oligosaccharide in the gel suspension is 0.1-5 g/100 mL, preferably 0.3-3 g/100 mL.
优选的,在上述生物敷料中,所述壳寡糖为壳聚糖的降解产物,分子量为1000~2500Da,聚合度为2~8;所述降解通过物理法、化学法或酶法来完成。Preferably, in the above-mentioned biological dressing, the oligochitosan is a degradation product of chitosan, with a molecular weight of 1000-2500 Da and a degree of polymerization of 2-8; the degradation is accomplished by physical, chemical or enzymatic methods.
优选的,在上述生物敷料中,所述凝胶混悬液中明胶的质量浓度为2~15g/100mL,优选4~14g/100mL。Preferably, in the above-mentioned biological dressing, the mass concentration of gelatin in the gel suspension is 2-15g/100mL, preferably 4-14g/100mL.
优选的,在上述生物敷料中,所述凝胶混悬液中镁黄长石的质量浓度为1~20g/100mL,优选1.5~10g/100mL。Preferably, in the above-mentioned biological dressing, the mass concentration of feldspar in the gel suspension is 1-20 g/100 mL, preferably 1.5-10 g/100 mL.
优选的,在上述生物敷料中,所述溶剂选自水、冰醋酸、甲酸、2,2,2-三氟乙醇(TFE)中的任意一种或其任意比例的混合物。Preferably, in the above-mentioned biological dressing, the solvent is selected from any one of water, glacial acetic acid, formic acid, 2,2,2-trifluoroethanol (TFE) or a mixture thereof in any proportion.
上述壳寡糖-明胶-镁黄长石纳米纤维生物敷料的制备方法,其包括下列步骤:The preparation method of above-mentioned oligochitosan-gelatin-magnesia feldspar nanofiber biological dressing, it comprises the following steps:
1)称取壳寡糖和明胶,加入到溶剂中溶胀过夜,于45~60℃搅拌0.5~2小时,得到凝胶状混合物;1) Weighing chitosan oligosaccharide and gelatin, adding them to a solvent to swell overnight, and stirring at 45-60°C for 0.5-2 hours to obtain a gel-like mixture;
2)研磨镁黄长石,直至粒径小于10μm,收集镁黄长石干粉,加入到步骤1)中得到的凝胶状混合物中,于45~60℃搅拌1~3小时,得到凝胶混悬液;2) Grinding feldspar until the particle size is less than 10 μm, collecting dry feldspar powder, adding it to the gel-like mixture obtained in step 1), and stirring at 45-60° C. for 1-3 hours to obtain a gel suspension;
3)通过静电纺丝的方法,将步骤2)中得到的凝胶混悬液制成直径为100~1000nm的纳米纤维,平铺形成纤维毡,得到壳寡糖-明胶-镁黄长石纳米纤维生物敷料。3) By electrospinning, the gel suspension obtained in step 2) is made into nanofibers with a diameter of 100-1000nm, and flattened to form a fiber mat to obtain chitooligosaccharide-gelatin-magnesia feldspar nanofiber biological dressing.
优选的,在上述制备方法中,步骤2)中所述研磨采用球磨机来完成,干法研磨4~6次,每次2~8分钟,转速为700~1200rpm。Preferably, in the above preparation method, the grinding in step 2) is done by using a ball mill, dry grinding 4 to 6 times, each time for 2 to 8 minutes, and the rotation speed is 700 to 1200 rpm.
优选的,在上述制备方法中,步骤3)中所述静电纺丝的参数如下:喷丝头内径为0.6mm,注射流量为0.2~1.5mL/h,电场强度为5~20kV/cm,电纺间距为10~20cm。Preferably, in the above preparation method, the electrospinning parameters described in step 3) are as follows: the inner diameter of the spinneret is 0.6mm, the injection flow rate is 0.2-1.5mL/h, the electric field strength is 5-20kV/cm, and the electric field strength is 5-20kV/cm. The spinning distance is 10-20cm.
与现有技术相比,采用上述技术方案的本发明具有如下优点:Compared with the prior art, the present invention adopting the above-mentioned technical solution has the following advantages:
1、本发明的复合型纳米纤维生物敷料克服了现有技术中采用单一敷料成分带来的弊端,能够更加适应皮肤组织的生物多样性和复杂性;1. The composite nanofiber biological dressing of the present invention overcomes the disadvantages of using a single dressing component in the prior art, and can better adapt to the biodiversity and complexity of skin tissue;
2、本发明的复合型纳米纤维生物敷料属于湿性敷料的范畴,既保证了创口处于湿性环境下,有利于加速血管形成,促进肉芽组织的形成,又保持了创面的恒温,有利于组织的无结痂愈合,避免了新生肉芽组织再次遭受机械性损伤;2. The composite nanofiber biological dressing of the present invention belongs to the category of moist dressings, which not only ensures that the wound is in a moist environment, but also helps to accelerate the formation of blood vessels, promote the formation of granulation tissue, and maintain the constant temperature of the wound surface, which is conducive to the non-toxicity of tissues. The scab heals, preventing the new granulation tissue from suffering mechanical damage again;
3、本发明的复合型纳米纤维生物敷料具有良好的保湿性、透气性、抑菌性、生物相容性,并且操作方便,易于使用。3. The composite nanofiber biological dressing of the present invention has good moisture retention, air permeability, bacteriostasis and biocompatibility, and is easy to operate and use.
具体实施方式detailed description
下面将通过具体的实施例对本发明做出进一步的详细说明,但是需要理解的是,下列实施例并非旨在限定本发明的保护范围。另外,除非特殊说明,下列实施例中所使用的仪器、材料、试剂等均可通过常规的商业手段获得。The present invention will be further described in detail through specific examples below, but it should be understood that the following examples are not intended to limit the protection scope of the present invention. In addition, unless otherwise specified, the instruments, materials, reagents, etc. used in the following examples can be obtained through conventional commercial means.
实施例1:壳寡糖-明胶-镁黄长石纳米纤维生物敷料的制备。Example 1: Preparation of oligochitosan-gelatin-magnesia feldspar nanofiber biological dressing.
(1)称取0.75g的壳寡糖(分子量为1000~2500Da,聚合度为2~8,由壳聚糖经化学法降解而得)和7.5g的明胶,加入到100mL的2%醋酸水溶液中溶胀过夜,于45℃搅拌2h,得到透明、粘稠的凝胶状混合物;(1) Weigh 0.75g of chitosan oligosaccharide (molecular weight is 1000-2500Da, degree of polymerization is 2-8, obtained by chemical degradation of chitosan) and 7.5g of gelatin, add to 100mL of 2% acetic acid aqueous solution Swell in medium overnight, stir at 45°C for 2 hours to obtain a transparent, viscous gel-like mixture;
(2)使用球磨机研磨2g的镁黄长石,干法研磨4次,每次研磨8min,转速为1200rpm,直至镁黄长石的粒径小于10μm,收集干粉,加入到上述凝胶状混合物中,于45℃搅拌3h,得到均匀的凝胶混悬液;(2) Use a ball mill to grind 2 g of feldspar feldspar, dry grinding 4 times, each time for 8 minutes, and the rotation speed is 1200 rpm, until the particle size of feldspar feldspar is less than 10 μm, collect the dry powder, add it to the above gel-like mixture, and dry it at 45 ° C Stir for 3h to obtain a uniform gel suspension;
(3)将上述凝胶混悬液经注射泵恒速挤出后,受到高压电场力作用被迫喷射拉伸至收集装置上(纤维直径为500nm),平铺形成纤维毡,得到壳寡糖-明胶-镁黄长石纳米纤维生物敷料,其中:静电纺丝所用喷丝头内径为0.6mm,注射流量为0.5mL/h,电场强度为10kV/cm,电纺间距为12cm。(3) After the above-mentioned gel suspension is extruded by a syringe pump at a constant speed, it is forced to be sprayed and stretched to a collection device (fiber diameter is 500nm) by a high-voltage electric field force, and flattened to form a fiber mat to obtain chitosan oligosaccharides - Gelatin-magnesia feldspar nanofiber biological dressing, wherein: the inner diameter of the spinneret used for electrospinning is 0.6mm, the injection flow rate is 0.5mL/h, the electric field strength is 10kV/cm, and the electrospinning distance is 12cm.
实施例2:壳寡糖-明胶-镁黄长石纳米纤维生物敷料的制备。Example 2: Preparation of oligochitosan-gelatin-magnesia feldspar nanofiber biological dressing.
(1)称取1g的壳寡糖(分子量为1000~2500Da,聚合度为2~8,由壳聚糖经酶法降解而得)和13g的明胶,加入到100mL的去离子水中溶胀过夜,于60℃搅拌1h,得到透明、粘稠的凝胶状混合物;(1) Weigh 1g of chitosan oligosaccharide (molecular weight is 1000~2500Da, degree of polymerization is 2~8, obtained by enzymatic degradation of chitosan) and 13g of gelatin, add to 100mL of deionized water to swell overnight, Stir at 60°C for 1 h to obtain a transparent, viscous gel-like mixture;
(2)使用球磨机研磨5g的镁黄长石,干法研磨6次,每次研磨6min,转速为700rpm,直至镁黄长石的粒径小于10μm,收集干粉,加入到上述凝胶状混合物中,于60℃搅拌1h,得到均匀的凝胶混悬液;(2) Use a ball mill to grind 5g of feldspar feldspar, dry grinding 6 times, each grinding 6min, rotating speed 700rpm, until the particle size of feldspar feldspar is less than 10μm, collect the dry powder, add it to the above gel mixture, at 60 ℃ Stir for 1h to obtain a uniform gel suspension;
(3)将上述凝胶混悬液经注射泵恒速挤出后,受到高压电场力作用被迫喷射拉伸至收集装置上(纤维直径为800nm),平铺形成纤维毡,得到壳寡糖-明胶-镁黄长石纳米纤维生物敷料,其中:静电纺丝所用喷丝头内径为0.6mm,注射流量为1mL/h,电场强度为15kV/cm,电纺间距为18cm。(3) After the above-mentioned gel suspension is extruded at a constant speed by a syringe pump, it is forced to be sprayed and stretched to a collection device (fiber diameter is 800nm) by a high-voltage electric field force, and flattened to form a fiber mat to obtain chitosan oligosaccharides - Gelatin-magnesia feldspar nanofiber biological dressing, wherein: the inner diameter of the spinneret used for electrospinning is 0.6mm, the injection flow rate is 1mL/h, the electric field strength is 15kV/cm, and the electrospinning distance is 18cm.
实施例3:壳寡糖-明胶-镁黄长石纳米纤维生物敷料的制备。Example 3: Preparation of oligochitosan-gelatin-magnesia feldspar nanofiber biological dressing.
壳寡糖2g,明胶12g,镁黄长石10g,2,2,2-三氟乙醇定容至100ml。Chitooligosaccharide 2g, gelatin 12g, feldspar 10g, 2,2,2-trifluoroethanol to 100ml.
操作步骤:Steps:
(1)称取2g的壳寡糖(分子量为1000~2500Da,聚合度为2~8,由壳聚糖经物理法降解而得)和12g的明胶,加入到2,2,2-三氟乙醇中溶胀过夜,于50℃搅拌1h,得到透明、粘稠的凝胶状混合物。(1) Weigh 2g of chitosan oligosaccharide (molecular weight is 1000-2500Da, degree of polymerization is 2-8, obtained by physical degradation of chitosan) and 12g of gelatin, add to 2,2,2-trifluoro Swell overnight in ethanol and stir at 50°C for 1 h to obtain a transparent, viscous gel-like mixture.
(2)使用球磨机研磨10g的镁黄长石,干法研磨5次,每次研磨6min,转速为1200rpm,直至镁黄长石粉粒径小于10μm,收集干粉,加入到上述凝胶状混合物中,于50℃搅拌1h,得到均匀的凝胶混悬液;(2) Use a ball mill to grind 10 g of feldspar feldspar, dry grind 5 times, grind for 6 minutes each time, and rotate at 1200 rpm until the particle size of feldspar feldspar powder is less than 10 μm, collect the dry powder, add it to the above-mentioned gelatinous mixture, and dry it at 50 Stir at ℃ for 1 h to obtain a uniform gel suspension;
(3)将上述凝胶混悬液经注射泵恒速挤出后,受到高压电场力作用被迫喷射拉伸至收集装置上(纤维直径为1000nm),平铺形成纤维毡,得到壳寡糖-明胶-镁黄长石纳米纤维生物敷料,其中:静电纺丝所用喷丝头内径为0.6mm,注射流量为0.6mL/h,电场强度为12kV/cm,电纺间距为15cm。(3) After the above-mentioned gel suspension is extruded at a constant speed by a syringe pump, it is forced to be sprayed and stretched to a collection device (fiber diameter is 1000nm) by a high-voltage electric field force, and flattened to form a fiber mat to obtain chitosan oligosaccharides - Gelatin-magnesia feldspar nanofiber biological dressing, wherein: the inner diameter of the spinneret used for electrospinning is 0.6mm, the injection flow rate is 0.6mL/h, the electric field strength is 12kV/cm, and the electrospinning distance is 15cm.
实施例4:复合纳米纤维生物敷料的吸湿性能测试。Example 4: Hygroscopic performance test of composite nanofiber biological dressing.
将实施例1~3中所得生物敷料裁成10mm×10mm的小块,干燥至恒重后,放在相对湿度为60%的环境中,定时称重,直至达到吸湿平衡。吸湿率(M)按照下式计算,其中Mx为吸湿后的重量,M0为吸湿前干重。The biological dressing obtained in Examples 1-3 was cut into small pieces of 10mm×10mm, dried to a constant weight, placed in an environment with a relative humidity of 60%, and weighed regularly until moisture absorption equilibrium was reached. The moisture absorption rate (M) is calculated according to the following formula, where M x is the weight after moisture absorption, and M 0 is the dry weight before moisture absorption.
上述吸湿率测试实验的结果(以“平均值±标准差”表示)如表1所示。The results of the above-mentioned moisture absorption test experiment (expressed as "mean ± standard deviation") are shown in Table 1.
表1.复合纳米纤维生物敷料的吸湿率结果Table 1. Results of moisture absorption rate of composite nanofiber bio-dressings
由表1中的结果可知,本发明的生物敷料均具有较好的吸湿性,并且壳寡糖和明胶的含量不同也影响了生物敷料的吸湿率,因此可以保证创口处于湿性环境下,有利于加速血管形成,促进肉芽组织的形成;同时,湿性环境保持了创面的恒温,有利于组织的无结痂愈合,避免了新生肉芽组织再次遭受机械性损伤,减轻疼痛。As can be seen from the results in Table 1, the biological dressing of the present invention has good hygroscopicity, and the different contents of chitosan and gelatin also affect the moisture absorption rate of the biological dressing, so it can ensure that the wound is in a humid environment, which is beneficial to Accelerate the formation of blood vessels and promote the formation of granulation tissue; at the same time, the humid environment maintains a constant temperature on the wound surface, which is conducive to the healing of tissues without scabs, avoids the new granulation tissue from being subjected to mechanical damage again, and reduces pain.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610780586.7A CN106215221A (en) | 2016-08-30 | 2016-08-30 | Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610780586.7A CN106215221A (en) | 2016-08-30 | 2016-08-30 | Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106215221A true CN106215221A (en) | 2016-12-14 |
Family
ID=58071685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610780586.7A Pending CN106215221A (en) | 2016-08-30 | 2016-08-30 | Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106215221A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108079378A (en) * | 2017-12-22 | 2018-05-29 | 中国科学院上海硅酸盐研究所 | Compound myocardium patching material of the organic/inorganic of active plasma diffusing W,Mo function and nanostructured and preparation method thereof |
CN108578757A (en) * | 2018-03-29 | 2018-09-28 | 青岛翰兴知识产权运营管理有限公司 | A kind of composite sponge hemostatic material and preparation method thereof |
CN113058068A (en) * | 2021-04-19 | 2021-07-02 | 上海交通大学医学院附属第九人民医院 | Preparation method of chitosan quaternary ammonium salt doped magnesium ion antibacterial dressing |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004071542A1 (en) * | 2003-02-14 | 2004-08-26 | The North West London Hospitals Nhs Trust | Bioactive material for use in stimulating vascularization |
CN1535731A (en) * | 2003-04-09 | 2004-10-13 | �����������﹤������˾ | New dressing matorial for promoting quick repair of surface of dermal wound |
CN102078638A (en) * | 2010-12-13 | 2011-06-01 | 都本立 | Long-acting combination type wound dressing and preparation method thereof |
CN103520764A (en) * | 2013-10-29 | 2014-01-22 | 成都迪康中科生物医学材料有限公司 | Functional dressing, and preparation method and application thereof |
CN104562438A (en) * | 2013-10-17 | 2015-04-29 | 中国科学院理化技术研究所 | Gelatin-based micro-nano fiber membrane material and preparation method and application thereof |
-
2016
- 2016-08-30 CN CN201610780586.7A patent/CN106215221A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004071542A1 (en) * | 2003-02-14 | 2004-08-26 | The North West London Hospitals Nhs Trust | Bioactive material for use in stimulating vascularization |
CN1535731A (en) * | 2003-04-09 | 2004-10-13 | �����������﹤������˾ | New dressing matorial for promoting quick repair of surface of dermal wound |
CN102078638A (en) * | 2010-12-13 | 2011-06-01 | 都本立 | Long-acting combination type wound dressing and preparation method thereof |
CN104562438A (en) * | 2013-10-17 | 2015-04-29 | 中国科学院理化技术研究所 | Gelatin-based micro-nano fiber membrane material and preparation method and application thereof |
CN103520764A (en) * | 2013-10-29 | 2014-01-22 | 成都迪康中科生物医学材料有限公司 | Functional dressing, and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
帅词俊等著: "《3D打印人工骨原理与技术》", 31 March 2016, 中南大学出版社 * |
张军林等主编: "《简明生物化学》", 30 June 2016, 华中师范大学出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108079378A (en) * | 2017-12-22 | 2018-05-29 | 中国科学院上海硅酸盐研究所 | Compound myocardium patching material of the organic/inorganic of active plasma diffusing W,Mo function and nanostructured and preparation method thereof |
CN108079378B (en) * | 2017-12-22 | 2020-09-18 | 中国科学院上海硅酸盐研究所 | Organic/inorganic composite myocardial patch material with active ion release function and nano structure and preparation method thereof |
CN108578757A (en) * | 2018-03-29 | 2018-09-28 | 青岛翰兴知识产权运营管理有限公司 | A kind of composite sponge hemostatic material and preparation method thereof |
CN113058068A (en) * | 2021-04-19 | 2021-07-02 | 上海交通大学医学院附属第九人民医院 | Preparation method of chitosan quaternary ammonium salt doped magnesium ion antibacterial dressing |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107693835B (en) | Polyvinyl alcohol/collagen/quaternized chitosan electrostatic spinning composite fiber film and preparation method thereof | |
CN101249274B (en) | Preparation of bletilla striata polyose water gelatin of promoting wound healing and uses thereof | |
CN104069537B (en) | Sodium alginate-sodium carboxymethyl cellulose-Chitosan in Wound Dressing and preparation method thereof | |
CN103550817B (en) | A kind of Bacterial cellulose/shitosan composite sponge dressing and preparation method thereof | |
CN102552964B (en) | Nano silver chitosan composite antibacterial composition, adhesive bandage and preparation method of adhesive bandage | |
Rajkumar et al. | Chitosan-based biomaterial in wound healing: a review | |
CN106215232A (en) | A kind of wound antibacterial promoting healing dressing and preparation method thereof | |
CN102908653A (en) | Preparation method of antiseptic dressing for deep infection wound | |
CN105833331A (en) | Preparation method for degradable biological wound dressing and obtained product | |
CN103505758A (en) | Chitosan-nanofiber hemostatic material and preparation method thereof | |
CN107496972B (en) | Anti-adhesion wet dressing for promoting burn wound healing and preparation method thereof | |
CN105079863A (en) | Preparation method of aloe/sodium alginate double-layer hydrogel dressing | |
CN114767925B (en) | Fluorescent pH-sensitive antibacterial hydrogel dressing and preparation method and application thereof | |
CN110975002A (en) | Hemostatic material for war wounds and preparation method and application thereof | |
AU2013306517B2 (en) | Active polymer layer made of chitin derivatives, especially for a dressing, and its use | |
CN109481148B (en) | A kind of moisture absorption vapor-permeable type wound dressing patch | |
CN115154642A (en) | Bionic asymmetric sponge dressing and preparation method thereof | |
CN106215221A (en) | Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof | |
CN102921035A (en) | Antiseptic dressing for deep infected wounds | |
Phulmogare et al. | Fucoidan loaded PVA/Dextran blend electrospun nanofibers for the effective wound healing | |
Yuan et al. | Recent advances in harnessing biological macromolecules for wound management: a review | |
Zhang et al. | Multifunctional xyloglucan-containing electrospun nanofibrous dressings for accelerating infected wound healing | |
CN103436992B (en) | Method for preparing nano drug-carrying capsule-loaded alginate fibers | |
CN108815381A (en) | It is a kind of for the Chinese medicine metatitanic acid silver composite porous material and preparation method of burn wound healing and application | |
CN109224124B (en) | Liquid dressing for stopping bleeding and promoting healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161214 |
|
RJ01 | Rejection of invention patent application after publication |